JAK2 V617F VAF as a diagnostic and prognostic marker for polycythemia vera and thrombosis risk
Alison Moliterno, MD, Johns Hopkins Medicine, Baltimore, MD, discusses the association between JAK2 V617F variant allele fraction (VAF), clinical phenotype, and venous thrombosis risk in patients with polycythemia vera (PV), discussing its role as a prognostic and diagnostic marker in this disease. This interview took place at the 14th International Congress on Myeloproliferative Neoplasms (MPN Congress) held in New York City, NY.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Watch video JAK2 V617F VAF as a diagnostic and prognostic marker for polycythemia vera and thrombosis risk online without registration, duration hours minute second in high quality. This video was added by user VJHemOnc – Video Journal of Hematology & HemOnc 15 November 2022, don't forget to share it with your friends and acquaintances, it has been viewed on our site 9,887 once and liked it 75 people.